These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity. Chalouhi GE, Golfier F, Soignon P, Massardier J, Guastalla JP, Trillet-Lenoir V, Schott AM, Raudrant D. Am J Obstet Gynecol; 2009 Jun 15; 200(6):643.e1-6. PubMed ID: 19393597 [Abstract] [Full Text] [Related]
16. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Mohit M, Sarraf Z, Sheikhi G, Robati M, Vasheghani-Farahani A. Arch Gynecol Obstet; 2009 Nov 15; 280(5):775-80. PubMed ID: 19263063 [Abstract] [Full Text] [Related]
17. Methotrexate infusion in low-risk gestational trophoblastic disease. Wong LC, Ngan HY, Cheng DK, Ng TY. Am J Obstet Gynecol; 2000 Dec 15; 183(6):1579-82. PubMed ID: 11120531 [Abstract] [Full Text] [Related]
18. Response to initial treatment of low and intermediate risk gestational trophoblastic disease with methotrexate and folinic acid. Tonanont M, Inthasorn P, Boriboonhirunsarn D, Wongthiraporn W, Suphanit I. J Med Assoc Thai; 2005 Oct 15; 88(10):1349-54. PubMed ID: 16519378 [Abstract] [Full Text] [Related]